SARS-CoV-2 Virus Antigen – Tijaabada guriga

Sharaxaad Gaaban:

Xirmadan ogaanshaha waxa loogu talagalay in vitro lagu ogaado tayada SARS-CoV-2 antigen ee shaybaarka suufka sanka.Tijaabadaan waxaa loogu talagalay isticmaalka guriga ee aan dhakhtar qorin ee is-tijaabinta is-ku-ururinta sanka hore ee sanka (nares) ee laga soo qaaday shakhsiyaadka da'doodu tahay 15 sano ama ka weyn ee looga shakisan yahay COVID-19 ama dadka waaweyn ee laga soo qaaday muunadaha suufka sanka ee shakhsiyaadka ka yar 15 sano kuwaas oo looga shakisan yahay COVID-19.


Faahfaahinta Alaabta

Tags Product

Magaca alaabta

HWTS-RT062IA/B/C-SARS-CoV-2 Xirmada ogaanshaha Antigen-ka (qaabka dahabka colloidal)-Sanka

Shahaado

CE1434

Epidemiology

Cudurka Coronavirus 2019 (COVID-19), waa oof wareenka uu keeno infekshanka cusub ee coronavirus oo loo yaqaan 'Severe Acute Respiratory Syndrome' Corona-Virus 2 (SARS-CoV-2).SARS-CoV-2 waa coronavirus novel ah oo ku jira hiddaha β, qaybo daboolan oo wareegsan ama oval ah, oo leh dhexroor 60 nm ilaa 140 nm.Aadanuhu guud ahaan wuu u nugul yahay SARS-CoV-2.Ilaha ugu muhiimsan ee caabuqa waa bukaannada COVID-19 ee la xaqiijiyay iyo sidaha asymptomatic ee SARSCoV-2.

Daraasad caafimaad

Waxqabadka Qalabka Baahinta Antigen-ka waxaa lagu qiimeeyay 554 bukaan oo sanka laga soo ururiyay tuhmanayaasha astaamaha ah ee COVID-19 7 maalmood gudahood ka dib markii ay calaamaduhu bilaabmeen marka la barbar dhigo baaritaanka RT-PCR.Waxqabadka Qalabka Tijaabada ee SARS-CoV-2 Ag waa sida soo socota:

SARS-CoV-2 Fayraska Antigen-ka RT-PCR reagent Wadarta
Wanagsan xun
Wanagsan 97 0 97
xun 7 450 457
Wadarta 104 450 554
Dareenka 93.27% 95.0% CI 86.62% - 97.25%
Gaar ahaan 100.00% 95.0% CI 99.18% - 100.00%
Wadarta 98.74% 95.0% CI 97.41% - 99.49%

Qiyaasaha Farsamada

Heerkulka kaydinta 4℃-30℃
Tusaalaha nooca Muunadaha suufka sanka
Nolosha shelf 24 bilood
Qalabka caawimada Looma baahna
Alaabta Dheeraadka ah Looma baahna
Waqtiga ogaanshaha 15-20 daqiiqo
Gaar ahaan Ma jiro falcelin iskutallaab ah oo leh cudur-sideyaasha sida Coronavirus aadanaha (HCoV-OC43, HCoV-229E, HCoV-HKU1, HCoV-NL63), Hargabka Novel A H1N1 (2009), hargab xilliyeed A (H1N1, H3N2, H5N1, H7N9) , Hargabka B (Yamagata, Victoria), Neefsashada fayraska syncytial A/B, Fayraska Parainfluenza (1, 2 iyo 3), Rhinovirus (A, B, C), Adenovirus (1, 2, 3, 4,5, 7, 55). ).

Socodka Shaqada

1. Muunad
Si tartiib ah u geli dhammaan caarada jilicsan ee suufka (sida caadiga ah 1/2 ilaa 3/4 inch) hal dalool oo sanka ah, Adigoo isticmaalaya cadaadis dhexdhexaad ah, ku xoq suufka dhammaan gidaarada gudaha ee sankaaga.Samee ugu yaraan 5 wareeg oo waaweyn.Dul kasta oo sankuna waa in lagu dhaqo ilaa 15 ilbiriqsi. Adigoo isticmaalaya suuf isku mid ah, ku celi isla sidaas oo kale sankaaga kale.

Muunad

Tusaalaha milankaGebi ahaanba suufka ku dhex daadi xalinta muunada;Jebi ul suufka meesha jaban, adigoo ka tagaya dhamaadka jilicsan ee tuubada.Dabool daboolka, leexi 10 jeer oo dhig tuubada meel xasilan.

2.Sample milanka
2.Sample milanka1

2. Samee imtixaanka
Ku rid 3 dhibcood oo ah muunada la soo saaray ee godka muunada ee kaadhka ogaanshaha, marooji furka.

Samee imtixaanka

3. Akhri natiijada (15-20 daqiiqo)

Akhri natiijada

  • Hore:
  • Xiga:

  • Halkan ku qor fariintaada oo noo soo dir